LICENSE AGREEMENTLicense Agreement • September 21st, 2021 • Seagen Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT (this “Agreement”) is signed as of August 8, 2021 (the “Execution Date”), by and between REMEGEN CO., LTD., a joint stock company that is incorporated in the People’s Republic of China with limited liability and that is located at 58 Beijing Middle Road, Yantai Shandong, China (“RemeGen”) and SEAGEN INC., a Delaware corporation located at 21823 30th Drive SE, Bothell, WA 98021, USA (“Seagen”). RemeGen and Seagen are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
